These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 33131965)

  • 1. Prophylactic Administration of Diphenhydramine to Reduce Neuroleptic Side Effects in the Acute Care Setting: A Systematic Review and Meta-Analysis.
    Mokhtari A; Yip O; Alain J; Berthelot S
    J Emerg Med; 2021 Feb; 60(2):165-174. PubMed ID: 33131965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant anticholinergic therapy for the prevention of akathisia in patients with primary headache in the emergency department: A systematic review.
    Meyer J; Kirkland SW; Campbell S; Villa-Roel C; Rowe BH
    Acad Emerg Med; 2023 Jan; 30(1):45-52. PubMed ID: 35962748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of prophylactic anticholinergic medications to decrease extrapyramidal side effects in patients taking acute antiemetic drugs: a systematic review and meta-analysis.
    D'Souza RS; Mercogliano C; Ojukwu E; D'Souza S; Singles A; Modi J; Short A; Donato A
    Emerg Med J; 2018 May; 35(5):325-331. PubMed ID: 29431143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug therapy for delirium in terminally ill adults.
    Finucane AM; Jones L; Leurent B; Sampson EL; Stone P; Tookman A; Candy B
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD004770. PubMed ID: 31960954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia.
    Soares-Weiser K; Rathbone J
    Cochrane Database Syst Rev; 2006 Jan; (1):CD000459. PubMed ID: 16437425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized trial of diphenhydramine as prophylaxis against metoclopramide-induced akathisia in nauseated emergency department patients.
    Friedman BW; Bender B; Davitt M; Solorzano C; Paternoster J; Esses D; Bijur P; Gallagher EJ
    Ann Emerg Med; 2009 Mar; 53(3):379-85. PubMed ID: 18814935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia.
    Declercq T; Petrovic M; Azermai M; Vander Stichele R; De Sutter AI; van Driel ML; Christiaens T
    Cochrane Database Syst Rev; 2013 Mar; (3):CD007726. PubMed ID: 23543555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benzodiazepines for neuroleptic-induced acute akathisia.
    Lima AR; Soares-Weiser K; Bacaltchuk J; Barnes TR
    Cochrane Database Syst Rev; 2002; 1999(1):CD001950. PubMed ID: 11869614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticholinergics for neuroleptic-induced acute akathisia.
    Rathbone J; Soares-Weiser K
    Cochrane Database Syst Rev; 2006 Oct; 2006(4):CD003727. PubMed ID: 17054182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticholinergics for neuroleptic-induced acute akathisia.
    Lima AR; Weiser KV; Bacaltchuk J; Barnes TR
    Cochrane Database Syst Rev; 2002; (3):CD003727. PubMed ID: 12137709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticholinergics for neuroleptic-induced acute akathisia.
    Lima AR; Weiser KV; Bacaltchuk J; Barnes TR
    Cochrane Database Syst Rev; 2004; (1):CD003727. PubMed ID: 14974032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluphenazine decanoate (depot) and enanthate for schizophrenia.
    Maayan N; Quraishi SN; David A; Jayaswal A; Eisenbruch M; Rathbone J; Asher R; Adams CE
    Cochrane Database Syst Rev; 2015 Feb; 2015(2):CD000307. PubMed ID: 25654768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central action beta-blockers versus placebo for neuroleptic-induced acute akathisia.
    Lima AR; Bacalcthuk J; Barnes TR; Soares-Weiser K
    Cochrane Database Syst Rev; 2004 Oct; 2004(4):CD001946. PubMed ID: 15495022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risperidone versus typical antipsychotic medication for schizophrenia.
    Hunter RH; Joy CB; Kennedy E; Gilbody SM; Song F
    Cochrane Database Syst Rev; 2003; (2):CD000440. PubMed ID: 12804396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Painful sensory symptoms in neuroleptic-induced extrapyramidal syndromes.
    Decina P; Mukherjee S; Caracci G; Harrison K
    Am J Psychiatry; 1992 Aug; 149(8):1075-80. PubMed ID: 1353315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quetiapine for schizophrenia.
    Srisurapanont M; Disayavanish C; Taimkaew K
    Cochrane Database Syst Rev; 2000; (3):CD000967. PubMed ID: 10908478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interventions for preventing delirium in hospitalised non-ICU patients.
    Siddiqi N; Harrison JK; Clegg A; Teale EA; Young J; Taylor J; Simpkins SA
    Cochrane Database Syst Rev; 2016 Mar; 3(3):CD005563. PubMed ID: 26967259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current topics in neuroleptic-induced extrapyramidal symptoms in Japan.
    Inada T; Yagi G
    Keio J Med; 1996 Jun; 45(2):95-9. PubMed ID: 8683905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amisulpride for schizophrenia.
    Mota NE; Lima MS; Soares BG
    Cochrane Database Syst Rev; 2002; 2002(2):CD001357. PubMed ID: 12076408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aripiprazole alone or in combination for acute mania.
    Brown R; Taylor MJ; Geddes J
    Cochrane Database Syst Rev; 2013 Dec; 2013(12):CD005000. PubMed ID: 24346956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.